TABLE 3.
Treatment and impact of treatment on driving of those participants with Tourette syndrome or chronic tic disorder who have a driver's license (n = 200)
| n (%) | |
|---|---|
| Type of treatment | |
| On medication for the tics | 51 (25.5) |
| Antipsychotics | 23 (11.5) |
| Guanfacine | 5 (2.5) |
| Other | 27 (13.5) |
| On medication for other reasons | 99 (49.5) |
| For attention‐deficit/hyperactivity disorder | 20 (10.0) |
| For obsessive–compulsive disorder | 17 (8.5) |
| For anxiety and/or depression | 53 (26.5) |
| For insomnia | 17 (8.5) |
| For other problems | 40 (20.0) |
| Previous behavioral treatment for the tics | 65 (32.5) |
| Treatment and driving | |
| Medication for the tics affects the driving | |
| Yes, helps with the driving | 20 (39.2) |
| Yes, impairs the driving | 9 (17.7) |
| No, does not affect the driving | 22 (43.1) |
| Medication for other reasons affects the driving | |
| Yes, helps with the driving | 17 (17.2) |
| Yes, impairs the driving | 9 (9.1) |
| No, does not affect the driving | 73 (73.7) |
| Behavioral treatment for the tics affects the driving | |
| Yes, helps with the driving | 14 (21.5) |
| Yes, impairs the driving | 0 (0) |
| No, does not affect the driving | 51 (78.5) |